Pinnacle Summer Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Pinnacle Summer Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,224	Closed	-$69K	–	999
2015 Q3	$69K	Buy	+1,224	New	+$79.4K	0.01%	437
2015 Q2	–	Sell	-1,533	Closed	-$96K	–	930
2015 Q1	$96K	Sell	1,533 -4,830	-76%	-$281K	0.01%	411
2014 Q4	$363K	Buy	6,363 +267	+4%	+$14.9K	0.04%	241
2014 Q3	$328K	Hold	6,096	–	–	0.04%	267
2014 Q2	$329K	Hold	6,096	–	–	0.04%	251
2014 Q1	$298K	Hold	6,096	–	–	0.04%	223
2013 Q4	$244K	Hold	6,096	–	–	0.03%	234
2013 Q3	$230K	Buy	6,096 +4,272	+234%	+$167K	0.04%	221
2013 Q2	$72K	Buy	+1,824	New	+$71K	0.02%	332

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Pinnacle Summer Investments's TEVA Position: Q4 2015 in Review

Pinnacle Summer Investments sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 1,224 shares — an estimated $69K sold.

Pinnacle Summer Investments first reported a position in TEVA in Q2 2013 and held it in 9 quarters. The position peaked at $363K in Q4 2014. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Pinnacle Summer Investments reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Pinnacle Summer Investments sold 1,224 Teva Pharmaceuticals shares in Q4 2015, an estimated $69K.
Pinnacle Summer Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Pinnacle Summer Investments's Teva Pharmaceuticals position peaked at $363K in Q4 2014.
877 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.